BIOMAT Database Logo BIOMAT Database Logo

The clinical significance of IgA antiphospholipid antibodies. 2001

M Samarkos, and R A Asherson, and S Loizou

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D016736 Antiphospholipid Syndrome The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). Anti-Phospholipid Antibody Syndrome,Anti-Phospholipid Syndrome,Antiphospholipid Antibody Syndrome,Hughes Syndrome,Anti Phospholipid Antibody Syndrome,Anti Phospholipid Syndrome,Antibody Syndrome, Anti-Phospholipid,Antibody Syndrome, Antiphospholipid,Antiphospholipid Antibody Syndromes,Syndrome, Anti-Phospholipid,Syndrome, Anti-Phospholipid Antibody,Syndrome, Antiphospholipid,Syndrome, Antiphospholipid Antibody,Syndrome, Hughes

Related Publications

M Samarkos, and R A Asherson, and S Loizou
Significance of IgA antiphospholipid antibodies.
January 1998, Lupus,
M Samarkos, and R A Asherson, and S Loizou
IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.
February 1998, Thrombosis and haemostasis,
M Samarkos, and R A Asherson, and S Loizou
The clinical significance of antiphospholipid antibodies.
April 1997, Annals of medicine,
M Samarkos, and R A Asherson, and S Loizou
[Clinical significance of antiphospholipid antibodies].
April 1998, Rinsho byori. The Japanese journal of clinical pathology,
M Samarkos, and R A Asherson, and S Loizou
IgA antiphospholipid antibodies.
February 1999, Thrombosis and haemostasis,
M Samarkos, and R A Asherson, and S Loizou
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
April 2008, Seminars in thrombosis and hemostasis,
M Samarkos, and R A Asherson, and S Loizou
[The diagnosis and clinical significance of antiphospholipid antibodies].
April 1992, Deutsche medizinische Wochenschrift (1946),
M Samarkos, and R A Asherson, and S Loizou
The clinical significance of non-criteria antiphospholipid antibodies in atypical antiphospholipid syndrome.
October 2025, Modern rheumatology,
M Samarkos, and R A Asherson, and S Loizou
[Diagnostic antiphospholipid antibodies and their clinical significance].
January 1994, Acta haematologica Polonica,
M Samarkos, and R A Asherson, and S Loizou
[Antiphospholipid antibodies: clinical significance and biological diagnosis].
January 2000, Annales de biologie clinique,
Copied contents to your clipboard!